Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer.
暂无分享,去创建一个
[1] S. Sternberg,et al. The cardiotoxicity of adriamycin and daunomycin in children , 1976, Cancer.
[2] D. V. Von Hoff,et al. Risk factors for doxorubicin-induced congestive heart failure. , 1979, Annals of internal medicine.
[3] M. Bristow,et al. Doxorubicin cardiac toxicity manifesting seven years after treatment. Case report and review. , 1986, The American journal of medicine.
[4] Charles E. L. Brown,et al. PERIPARTUM HEART FAILURE IN A PATIENT TREATED PREVIOUSLY WITH DOXORUBICIN , 1988, Obstetrics and gynecology.
[5] E. Gelfand,et al. Reversal of chronic polymyositis following intravenous immune serum globulin therapy. , 1987, JAMA.
[6] S. Sallan,et al. Congestive heart failure due to adriamycin cardiotoxicity: Its natural history in children , 1981, Cancer.
[7] J. Aarli,et al. Guillain‐Barré syndrome: Demonstration of antibodies to peripheral nerve tissue , 1978, Acta neurologica Scandinavica.
[8] D. Driscoll,et al. Cardiopulmonary function in long-term survivors of childhood Hodgkin's lymphoma: a pilot study. , 1988, Mayo Clinic proceedings.
[9] J. Ware,et al. Echocardiographic Measurements in Normal Subjects , 1978, Circulation.
[10] J. Mcleod,et al. Electrophysiological studies in the Guillain‐Barré syndrome , 1981, Annals of neurology.
[11] M. Shin,et al. Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation. , 1985, Proceedings of the National Academy of Sciences of the United States of America.